Literature DB >> 19721173

[Third generation sub-mid urethral mesh: experience with 110 TVT-SECUR].

Vicente Solà1, Paolo Ricci, Jack Pardo.   

Abstract

OBJECTIVES: To review the effectiveness and security of the TVT-Secur system in the surgical treatment of stress urinary incontinence(SUI).
METHODS: Prospective analysis of 110 patients undergoing SUI surgical treatment in the Urogynecology and Vaginal Surgery Unit of Clínica Las Condes, between January 2007 and May 2008. The patients must have stress urinary incontinence over one year or more. They must not have history of a previous surgery for urinary incontinence or prolapse. They must not have mixed monstrated by clinical symptoms and non-multichannel urodynamic study.
RESULTS: Mean surgical time was 8 minutes (6 to 16 minutes). The observational period was between 2 months (4 cases) and 19 months, mean 8 months. During the intraoperative time 2 cases of bladder perforation were registered. In the immediate postoperative time 2 cases of obstruction were observed. In 97 (88,2%) of the 110 patients some concomitant gynecological surgery was performed. In 105 (95,5%) of the 110 cases cure of the SUI was registered. In 4 (3,6%) cases improvement was observed and 1 (0,9%) case was a failure. In 2 (1,8%) patients de novo urge incontinence was registered.
CONCLUSIONS: The TVT-Secur system corresponds to a third generation tape effective and safe in the surgical treatment of stress urinary incontinence. This technique has potential advantages when compared with the preceding operations. Only the long time follow-up and incorporation of new patients will allow to determine the permanence of these good results in the time.

Entities:  

Mesh:

Year:  2009        PMID: 19721173     DOI: 10.4321/s0004-06142009000500007

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  7 in total

1.  One-year results of a prospective randomized, evaluator-blinded, multicenter study comparing TVT and TVT Secur.

Authors:  Maria Andrada Hamer; Per-Göran Larsson; Pia Teleman; Christina Eten Bergqvist; Jan Persson
Journal:  Int Urogynecol J       Date:  2012-06-16       Impact factor: 2.894

2.  Comment on Palma and Rosenbaum: "the ethical challenge of surgical innovation".

Authors:  Vicente Solà; Paolo Ricci; Jack Pardo
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-07-28

3.  Short-term results of a prospective randomized evaluator blinded multicenter study comparing TVT and TVT-Secur.

Authors:  Maria Andrada Hamer; Per-Göran Larsson; Pia Teleman; Christina Etén-Bergqvist; Jan Persson
Journal:  Int Urogynecol J       Date:  2011-04-16       Impact factor: 2.894

Review 4.  [Diagnosis and treatment of overactive bladder, neurourology, urogynaecology and urinary stress incontinence: latest publications from 2009 and 2010].

Authors:  M A Reiter; A Oeztuerk; M Kurosch; A Haferkamp
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

5.  Contasure-Needleless compared with transobturator-TVT for the treatment of stress urinary incontinence.

Authors:  Lluís Amat I Tardiu; Eva Martínez Franco; Josep Maria Laïlla Vicens
Journal:  Int Urogynecol J       Date:  2011-03-02       Impact factor: 2.894

6.  Single-incision sling compared with transobturator sling for treating stress urinary incontinence: a randomized controlled trial.

Authors:  Ana Maria H M Bianchi-Ferraro; Zsuzsanna I K Jarmy-Di Bella; Rodrigo de A Castro; Maria Augusta T Bortolini; Marair G F Sartori; Manoel J B C Girão
Journal:  Int Urogynecol J       Date:  2012-12-04       Impact factor: 2.894

7.  Randomized controlled trial comparing TVT-O and TVT-S for the treatment of stress urinary incontinence: 2-year results.

Authors:  Ana Maria H M Bianchi-Ferraro; Zsuzsanna I K Jarmy-DiBella; Rodrigo de Aquino Castro; Maria Augusta T Bortolini; Marair G F Sartori; Manoel J B C Girão
Journal:  Int Urogynecol J       Date:  2014-03-19       Impact factor: 2.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.